Takeda Pharmaceutical
TAK
#450
Rank
A$80.43 B
Marketcap
A$24.17
Share price
-1.04%
Change (1 day)
17.65%
Change (1 year)

Market capitalization of Takeda Pharmaceutical (TAK)

Market cap: A$80.43 Billion

As of January 2026 Takeda Pharmaceutical has a market cap of A$80.43 Billion. This makes Takeda Pharmaceutical the world's 450th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Takeda Pharmaceutical from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026A$80.43 B3.45%
2025A$77.75 B14.85%
2024A$67.70 B2.37%
2023A$66.13 B-7.22%
2022A$71.27 B20.98%
2021A$58.91 B-20.41%
2020A$74.02 B-16.36%
2019A$88.50 B137.69%
2018A$37.23 B-34.36%
2017A$56.73 B25.53%
2016A$45.19 B-16.81%
2015A$54.32 B34.64%
2014A$40.34 B-0.86%
2013A$40.69 B19.5%
2012A$34.05 B0.31%
2011A$33.95 B-10.29%
2010A$37.84 B4.79%
2009A$36.11 B-44.36%
2008A$64.91 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Takeda Pharmaceutical was reported to be:

A$76.05 Billion
by Nasdaq info icon info icon
A$80.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$788.01 B 879.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$169.26 B 110.43%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$218.14 B 171.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$414.27 B 415.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
A$64.55 B-19.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$16.09 B-79.99%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
A$266.13 B 230.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$145.77 B 81.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$406.60 B 405.49%๐Ÿ‡บ๐Ÿ‡ธ USA